Bristol Myers Squibb
Dr. Fan Wu is a Director at Bristol Myers Squibb (BMS). As a Clinical Pharmacology & Pharmacometrics lead, he has specific interests in applying quantitative pharmacology modeling strategies to facilitate translational and clinical drug development. Formerly, he was Senior Principal Scientist at Celgene (acquired by BMS in 2019) and Senior Investigator at Novartis, and before that Senior Research Scientist at CFD Research Corporation. Fan received his PhD degree in Chemical Engineering at the University of New Hampshire and postdoctoral training in Systems Physiology from Professor Daniel Beard’s lab at the Medical College of Wisconsin. He has published more than 30 peer-reviewed research papers in leading scientific journals.